Interestingly, the cumulative risks of breast or ovarian cancer for Korean BRCA1 or BRCA2 carriers by region of BCCR or OCCR showed a different trend than what was previously reported [22] (Tables S15 and S16). This evidence concerns the gene BRCA2 and ovarian cancer.